Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Enzymedica, Incappointment of Scott Sensenbrenner to the position of Chief Executive Officer.Enzymedica, Inc., a manufacturer of enzyme focused supplements announces the appointment of Scott Sensenbrenner to the position of Chief Executive Officer.
By: Art Low Sensenbrenner leadership brings a great mix of inspiration, operational experience and a passion for customer care. While his background includes working for Enzymatic Therapy where he built the market for several leading products such as GS500, IP-6, Esberitox, St. John’s Wort, and Remifemin. Along with Perrigo as Group Director of their Nutrition Division, OTC/nutritional organizations in the world with over $2 Billion in sales. Most recently, Sensenbrenner served as Vice President of Marketing & Sales for Thorne Research a leading manufacturer and marketer of therapeutic supplements sold exclusively to health care practitioners. As Chief Executive Officer, Sensenbrenner’ Tom Bohager, Enzymedica’s Founder and Operating Chairman will remain active in key decisions, sharing jointly with Sensenbrenner in the development of short and long range strategies for the company. To learn more about Enzymedica, visit the company website. http://www.enzymedica.com # # # Enzyme Supplements - Digestive Enzymes - High quality enzymes and enzyme supplements by Enzymedica: the Enzyme Experts. End
Account Email Address Disclaimer Report Abuse
|
|